EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human papillomavirus prevalence, genotype distribution, and prognostic factors of vaginal cancer

Hsiu-Jung Tung iD, You-Chen Wang, Chiao-Yun Lin iD, Min-Jie Liao, Yu-Bin Pan, Shih-Ming Jung, Chun-Chieh Wang, Huei-Jean Huang, Angel Chao iD, Hung-Hsueh Chou, Ting-Chang Chang iD, Lan-Yan Yang iD und 1 weitere

International Journal of Cancer · 2024-12 · 155 (11) · 1996-2008

DOI: 10.1002/ijc.35105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 24.07.2024. Verfasst von Hsiu-Jung Tung und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Branch and Chang Gung University College of Medicine, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Papillomavirus Infections, Vaginal Neoplasms, Genotype. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare, Taiwan, Chang Gung Medical Foundation, Taiwan, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to investigate human papillomavirus (HPV) prevalence and genotype distribution and prognostic factors in vaginal cancer (VC). VC patients who received treatment between 1989 and 2020 were retrospectively reviewed. L1 general polymerase chain reaction (PCR) followed by HPV Blot (King Car, I‐Lan, Taiwan) and E6 type‐specific‐PCR were performed for genotyping firstly. P16 and p53 immunohistochemistry staining was performed. Univariate and multivariate analyses identified predictors of clinical outcomes.79 VC patients were eligible for analysis. 73 patients (92.4%) were squamous cell carcinoma (SCC) and 6 (7.6%) as non‐SCC. The median follow‐up time was 134.3 months (range 0.9–273.4). Among nine initially HPV‐negative cases, seven were identified as being positive through HPV16/18/45/52/58 whole‐genome amplification followed by Sanger sequencing (WGASS). HPV DNA sequences were detected in 98.6% of SCC and 83.3% of non‐SCC, respectively, with HPV16 (49.4%), HPV52 (15.2%) and HPV58 (8.9%) being predominant. Patients with paraaortic lymph node (LN) metastasis had a 5‐year cancer‐specific survival (CSS) rate of 0%. Multivariate analysis revealed that only p16 and stage were significantly correlated with prognosis. Variables with strong correlations (p16‐ and HPV‐positivity, LN metastasis and stage), were included in models 2–5 alternatively. Stage III/IV (hazard ratio [HR] = 3.64–4.56) and LN metastasis (HR = 2.81–3.44) were significant negative predictors of CSS, whereas p16‐positivity (HR = 0.29–0.32) and HPV‐positivity (HR = 0.14) were related to better prognosis. In conclusion, 97.5% of VCs were HPV‐positive with WGASS. Stage III/IV and LN metastasis were significant negative predictors, whereas p16‐ and HPV‐positivity were significantly associated with better prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsVaginal NeoplasmsGenotypeHumansFemaleMiddle AgedPrognosisAgedRetrospective StudiesAdultPrevalenceCarcinoma, Squamous CellPapillomaviridaeAged, 80 and overDNA, ViralLymphatic MetastasisHuman Papillomavirus Viruses

Stichwörter der Autor:innen

human papillomavirusp16prognosisvaginal cancer

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Branch and Chang Gung University College of Medicine, Taoyuan, Taiwan.
  • Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Linkou Branch and Chang Gung University College of Medicine, Taoyuan, Taiwan.
  • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Keelung Branch and Chang Gung University College of Medicine, Keelung, Taiwan.
  • Clinical Trial Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Department of Pathology, Chang Gung Memorial Hospital, Linkou Branch and Chang Gung University College of Medicine, Taoyuan, Taiwan.
  • Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou Branch and Chang Gung University College of Medicine, Taoyuan, Taiwan.

ORCID-Profile: Hsiu-Jung Tung, Chiao-Yun Lin, Angel Chao, Ting-Chang Chang, Lan-Yan Yang, Chyong-Huey Lai

Förderung

  • Ministry of Health and Welfare, Taiwan
  • Chang Gung Medical Foundation, Taiwan
  • Ministry of Health and Welfare
  • Chang Gung Medical Foundation

Zitieren

APA

Tung, H. J., Wang, Y. C., Lin, C. Y., Liao, M. J., Pan, Y. B., Jung, S. M., Wang, C. C., Huang, H. J., Chao, A., Chou, H. H., Chang, T. C., Yang, L. Y., & Lai, C. H. (2024). Human papillomavirus prevalence, genotype distribution, and prognostic factors of vaginal cancer. International Journal of Cancer, 155(11), 1996-2008. https://doi.org/10.1002/ijc.35105

Vancouver

Tung HJ, Wang YC, Lin CY, Liao MJ, Pan YB, Jung SM, et al. Human papillomavirus prevalence, genotype distribution, and prognostic factors of vaginal cancer. International Journal of Cancer. 2024;155(11):1996-2008. doi:10.1002/ijc.35105

BibTeX
@article{Tung2024,
  author = {Tung, Hsiu-Jung and Wang, You-Chen and Lin, Chiao-Yun and Liao, Min-Jie and Pan, Yu-Bin and Jung, Shih-Ming and Wang, Chun-Chieh and Huang, Huei-Jean and Chao, Angel and Chou, Hung-Hsueh and Chang, Ting-Chang and Yang, Lan-Yan and Lai, Chyong-Huey},
  title = {Human papillomavirus prevalence, genotype distribution, and prognostic factors of vaginal cancer},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {155},
  number = {11},
  pages = {1996--2008},
  doi = {10.1002/ijc.35105}
}
Kostenlos starten →